Remove Biopharma Remove Biotechnology Remove Collaboration Remove IT partnerships
article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

Simtra BioPharma Solutions announced over $250 million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana. FUJIFILM Diosynth Biotechnologies invested $1.6 Recipharm collaborated with Medspray and Resyca for developing both single and combination drug products.